Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Edition
European
US
Microbiology & Infectious Diseases
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Shorter Antibiotic Duration Shows Promise in Endocarditis: ESC 2026
September 2026
A tailored treatment strategy reduced antibiotic duration by 15 days in patients with left sided infective endocarditis in the POET-II trial, presented during ESC Congress 2026.
Read more
1 Sep 2026
Shorter Antibiotic Duration Shows Promise in Endocarditis: ESC 2026
A tailored treatment strategy reduced antibiotic duration by 15 days in patients with left sided infective endocarditis in the POET-II trial, presented during ESC Congress 2026.
30 Aug 2026
New Assay Could Simplify HIV Drug Resistance Testing
An optimised reverse transcriptase assay detected very low HIV viral loads and phenotypic drug resistance in around 2 hours, potentially offering a more accessible approach to resistance monitoring.
28 Aug 2026
tRNA Signature Could Distinguish HIV-2 from HIV-1
A six-tRNA biomarker panel detected HIV-2 and differentiated it from HIV-1 with 100% accuracy in an early proof-of-concept study, offering a potential host-derived approach to HIV diagnosis.
26 Aug 2026
Prone Sleeping Linked to Higher Nasal Bacterial Levels in Infants
Researchers found that prone positioning increased bacterial titres in the anterior nares, particularly during respiratory illness, providing further evidence for a proposed bacterial contribution to sudden infant death syndrome.
23 Aug 2026
MHRA Reaffirms Childhood Vaccine Safety Amid Autism Concerns
UK medicines regulator highlights evidence from millions of children showing no association between vaccination and autism
21 Aug 2026
S. anginosus
Infections Rise Sharply Across the UK
UK surveillance data reveal a substantial increase in serious Streptococcus anginosus group infections
17 Aug 2026
Candida auris
Emerges as Leading Cause of Candidaemia
Southern China has identified Candidozyma auris, formerly known as Candida auris, as the most common cause of candidemia in a tertiary hospital, with all isolates resistant to fluconazole.
16 Aug 2026
Antimicrobial Resistance is Linked to Poorer Pancreatic Outcomes
Antimicrobial resistance and Enterococcus infections were associated with delayed resolution, more interventions and poorer outcomes after pancreatic fluid collection therapy.
Loading posts...
1
2
3
…
54
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View